Game On: Medicare Will Parry Manufacturer Efforts To Sidestep Price Negotiation, Guidance Says

CMS will need to continue to be ‘savvy’ to strategies brand manufacturers already employ to shape the landscape for generic and biosimilar competition, policy expert says.